Clinical Trial Update: Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry)

View source ↗

Summary

The GENTLE Registry study updates on the Genoss drug-eluting stent in patients with high risk of ischemic events; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• GENOSS DES

Snippet

Sponsor: Yonsei University | Conditions: Drug-eluting Stent, Coronary Artery Disease | Status: COMPLETED